These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6843652)

  • 1. Predicted nucleotide-binding properties of p21 protein and its cancer-associated variant.
    Wierenga RK; Hol WG
    Nature; 1983 Apr; 302(5911):842-4. PubMed ID: 6843652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.
    Reddy EP; Reynolds RK; Santos E; Barbacid M
    Nature; 1982 Nov; 300(5888):149-52. PubMed ID: 7133135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology between human bladder carcinoma oncogene product and mitochondrial ATP-synthase.
    Gay NJ; Walker JE
    Nature; 1983 Jan; 301(5897):262-4. PubMed ID: 6296696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous activation of a human proto-oncogene.
    Santos E; Reddy EP; Pulciani S; Feldmann RJ; Barbacid M
    Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4679-83. PubMed ID: 6308640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the three-dimensional structure of the transforming region of the EJ/T24 human bladder oncogene product and its normal cellular homologue.
    Pincus MR; van Renswoude J; Harford JB; Chang EH; Carty RP; Klausner RD
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5253-7. PubMed ID: 6577419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene.
    Reddy EP
    Science; 1983 Jun; 220(4601):1061-3. PubMed ID: 6844927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphate-binding sequences in nucleotide-binding proteins.
    Möller W; Amons R
    FEBS Lett; 1985 Jul; 186(1):1-7. PubMed ID: 2989003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical amino acids of p21 protein are located within beta-turns: further evaluation.
    Murakami M
    J Theor Biol; 1987 Oct; 128(3):339-47. PubMed ID: 3328019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophosphorylation of v-Ha-ras p21 is modulated by amino acid residue 12.
    Gibbs JB; Ellis RW; Scolnick EM
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2674-8. PubMed ID: 6609366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a human transforming gene isolated from T24 bladder carcinoma cells.
    Santos E; Pulciani S; Barbacid M
    Fed Proc; 1984 May; 43(8):2280-6. PubMed ID: 6325252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of ras genes in human tumors does not affect localization, modification, or nucleotide binding properties of p21.
    Finkel T; Der CJ; Cooper GM
    Cell; 1984 May; 37(1):151-8. PubMed ID: 6609772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding.
    Clark R; Wong G; Arnheim N; Nitecki D; McCormick F
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5280-4. PubMed ID: 3927300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.
    Yuasa Y; Srivastava SK; Dunn CY; Rhim JS; Reddy EP; Aaronson SA
    Nature; 1983 Jun; 303(5920):775-9. PubMed ID: 6866079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins.
    Lacal JC; Santos E; Notario V; Barbacid M; Yamazaki S; Kung H; Seamans C; McAndrew S; Crowl R
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5305-9. PubMed ID: 6089191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural effects of substitutions on the p21 proteins.
    Pincus MR; Brandt-Rauf PW
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3596-3600. PubMed ID: 3923480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the conformation and GTP hydrolysing ability of N-terminal ras p21 protein segments.
    Niu CH; Han KH; Roller PP
    Biochem Biophys Res Commun; 1989 Apr; 160(1):282-8. PubMed ID: 2785386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody reactive with an activated ras protein expressing valine at position 12.
    Carney WP; Hamer P; Petit D; Wolfe H; Cooper G; Lefebvre M; Rabin H
    J Cell Biochem; 1986; 32(3):207-14. PubMed ID: 3536974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of activated Mr 21,000 protein, the product of ras oncogenes, using antibodies with specificity for amino acid 12.
    Wong G; Arnheim N; Clark R; McCabe P; Innis M; Aldwin L; Nitecki D; McCormick F
    Cancer Res; 1986 Dec; 46(12 Pt 1):6029-33. PubMed ID: 3490906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.
    Stacey DW; Kung HF
    Nature; 1984 Aug 9-15; 310(5977):508-11. PubMed ID: 6611509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue.
    Capon DJ; Chen EY; Levinson AD; Seeburg PH; Goeddel DV
    Nature; 1983 Mar; 302(5903):33-7. PubMed ID: 6298635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.